E Fund Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

E Fund Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,313	Closed	-$162K	–	388
2024 Q1	$162K	Buy	+10,313	New	+$159K	0.01%	357
2023 Q3	–	Sell	-12,429	Closed	-$175K	–	326
2023 Q2	$175K	Sell	12,429 -859	-6%	-$12.3K	0.01%	286
2023 Q1	$205K	Buy	13,288 +49	+0.4%	+$818	0.02%	295
2022 Q4	$217K	Sell	13,239 -648	-5%	-$10.5K	0.02%	289
2022 Q3	$257K	Sell	13,887 -4,066	-23%	-$63.8K	0.02%	258
2022 Q2	$236K	Sell	17,953 -3,237	-15%	-$35.7K	0.02%	269
2022 Q1	$196K	Buy	21,190 +3,257	+18%	+$27.7K	0.01%	299
2021 Q4	$175K	Buy	+17,933	New	+$337K	0.01%	272

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

E Fund Management's DCPH Position: Q2 2024 in Review

E Fund Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 10,313 shares — an estimated $162K sold.

E Fund Management first reported a position in DCPH in Q4 2021 and held it in 8 quarters. The position peaked at $257K in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

E Fund Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
E Fund Management sold 10,313 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $162K.
E Fund Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
E Fund Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $257K in Q3 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.